ArticleCureus2025
Macrophage Activation Syndrome Revealing Hodgkin Lymphoma: A Pediatric Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary macrophage activation syndrome is a severe and rare complication of infectious, autoimmune, and malignant diseases. Herein, we report the case of a 10-year-old child with this syndrome leading to the discovery of Hodgkin lymphoma. The patient, who had a medical history of cerebral palsy and ataxia-telangiectasia syndrome, was admitted for prolonged fever associated with cough, which had evolved into general health deterioration for two months prior to admission. He received multiple courses of antibiotic therapy for suspected pneumonia without clinical improvement. Clinical examination showed pallor, deteriorated general condition, high fever, asthenia, cervical adenopathy, and splenomegaly. The clinical and biological criteria led to the diagnosis of macrophage activation syndrome. Lymph node histology confirmed the diagnosis of Hodgkin lymphoma, which was staged as stage IV via positron emission tomography scan. The "vincristine, etoposide, prednisone, and doxorubicin" (OEPA) chemotherapy regimen was initiated, followed by the "cyclophosphamide, vincristine, prednisone, and dacarbazine" (COPDAC) regimen, with remission achieved both clinically and paraclinically after one cycle of each regimen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.